David D. Manning

发表

Development and Assessment of Battlefield Visualization Training for Battalion Commanders

Carl W. Lickteig, Scott B. Shadrick, James Bell, 2008 .

Methods and Tools for Training Crisis Response

Laura A. Zimmerman, James Bell, Christopher A. Burns, 2012 .

2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.

David D. Manning, P. Sampson, N. Kaplan, 2009, Bioorganic & medicinal chemistry letters.

Neoglycopolymer inhibitors of the selectins

David D. Manning, L. Kiessling, L. E. Strong, 1997 .

Synthesis of Sulfated Neoglycopolymers: Selective P-Selectin Inhibitors

David D. Manning, L. Kiessling, P. Beck, 1997 .

Synthesis and SAR of vinca alkaloid analogues.

Jason M. Stevens, David D. Manning, M. Voss, 2009, Bioorganic & medicinal chemistry letters.

Synthesis of sulfated trisaccharide ligands for the selectins

David D. Manning, K. M. Koeller, L. Kiessling, 1997 .

Tin-mediated phosphorylation: Synthesis and selectin binding of a phospho Lewis a analog

David D. Manning, C. Bertozzi, L. Kiessling, 1996 .

Preparation of (r)-(+)-7-oxabicyclo[2.2.1]hept-5-ene-exo-2-carboxylic acid, a precursor to substrates for the ring opening metathesis polymerization

David D. Manning, L. Kiessling, C. Schueller, 1996 .

A Library Approach to the Discovery of Small Molecules That Recognize RNA: Use of a 1,3-Hydroxyamine Motif as Core

David D. Manning, Chi‐Huey Wong, M. Hendrix, 1998 .

The effects of interleukin-15 on human γδ T cell responses to Plasmodium falciparum in vitro

David D. Manning, M. Elloso, M. Wallace, 1998 .

Partial agonism of 5-HT3 receptors: a novel approach to the symptomatic treatment of IBS-D.

David D. Manning, N. Moore, B. Sargent, 2013, ACS chemical neuroscience.

Selectin-Saccharide Interactions: Revealing Structure-Function Relationships with Chemical Synthesis

David D. Manning, C. Bertozzi, L. Kiessling, 1995 .

Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors.

David D. Manning, J. Wityak, D. Kitchen, 2015, Journal of medicinal chemistry.

Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.

David D. Manning, N. Barnes, C. Brady, 2011, Bioorganic & medicinal chemistry letters.

The discovery of diazepinone-based 5-HT3 receptor partial agonists.

David D. Manning, N. Barnes, C. Brady, 2014, Bioorganic & medicinal chemistry letters.

Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.

David D. Manning, Jianqing Chen, Marlene L. Cohen, 2010, Bioorganic & medicinal chemistry letters.

CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome

David D. Manning, A. Cooper, K. Brock, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.

David D. Manning, A. Cooley, H. C. van der Heyde, 1996, Journal of immunology.

Organozirconium Chemistry onCyclosporin: A Novel Process for the Highly Stereoselective Synthesisof (E)-ISA247 (Voclosporin) and CloseAnalogues

David D. Manning, F. Bois, J. Maeng, 2012 .